openPR Logo
Press release

Medicinal Cannabis Market- Global Industry Insights, and Opportunity Analysis, 2016-2024

10-13-2017 02:19 PM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Medicinal Cannabis Market- Global Industry Insights,

Medicinal cannabis, also known as medicinal marijuana, is used either to treat disease or improve symptoms. Cannabis has been considered to be a major source of drug addiction. Extract from the dried flower bud part of the plant called as Marijuana has certain medicinal properties. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are being used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.

Medicinal Cannabis Market Dynamics

However, the debate still continues regarding the approval, safety and usage of cannabis (marijuana) for medicinal purpose, due to differences in the laws pertaining to this smoked drug. Hence, studies are conducted extensively to establish the safety aspect of this drug. Various states in the U.S. have already legalized cannabis (marijuana) for medicinal purposes. Scientific research of chemicals in the cannabis plant for its potential medicinal use has led to a shift in its demand purpose. Regulatory clearance has played a major role in the growth of medicinal cannabis market.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/40

Other names of Cannabis - grass, pot, dope, Mary Jane, hooch, weed, hash, joints, brew, reefers, cones, smoke, mull, buddha, ganga, hydro, yarndi, heads, and green.

The U.S. FDA has approved two medications, Marinol and Syndros, which contain dronabinol in pill form. However, the FDA has not approved the marijuana plant as a medicine. The medicinal cannabis (marijuana) is administered in either of the ways – liquid extract, vaporized form, smoked or solid form.

Prevalent Scenario in the Medicinal Cannabis Market

According to the Medical Marijuana, Inc., the estimated size of the legal marijuana industry in the U.S. is US$ 7.1 billion in 2016. This is an increase of 25% Y-o-Y. As of 2016, 28 states in the U.S. have legalized marijuana for medicinal purpose with some more gearing up for votes on the recreational use of marijuana. California, Nevada, Maine, and Massachusetts states in November 2016, voted to legalize the recreational use of marijuana. The accelerated pace of legalization of cannabis (marijuana) in the U.S. has attracted the attention of global investors in the medicinal cannabis market. However, lack of formulation of a comprehensive law pertaining to medicinal marijuana in some states inhibits patient access to the drug.

Important role of Regulatory Authorities in the Medicinal Cannabis Market Trends

According to the United Nations, marijuana was the most widely used drug globally in 2014, with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is still conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain, inflammation, seizures, mental disorders, and substance abuse disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) medicines, as well as the capacity for the manufacturers in the medical cannabis market to be responsive, scalable, and innovative.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/medicinal-cannabis-market-40

Medicinal Cannabis Market Future Outlook

Potential medicinal cannabis markets other than the U.S., include Canada, Israel, Australia, and Spain. Mexico is also in process to consider the legalization of cannabis. Other countries are expected to consider legalization of the drug, once conclusive evidence regarding the safety and efficacy of cannabis are obtained through extensive research. According to Arcview Group—a cannabis industry investment and research firm—around 200 investors met companies to capitalize on lucrative opportunities from commercialization of medicinal cannabis. This implies that there is a huge potential in the medicinal cannabis industry and pharmaceutical and biotechnology companies need to focus on increasing awareness about the drug emerging economies.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Medicinal Cannabis Market- Global Industry Insights, and Opportunity Analysis, 2016-2024 here

News-ID: 773030 • Views: 337

More Releases from Pharmaceutical Report By CMI

Rising prevalence of diabetes is a major factor driving growth of the diabetic f …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the
Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Increasing prevalence of multiple sclerosis to augment market growth Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. According to the Multiple Sclerosis Foundation, 2017, this autoimmune condition affects 2.5 million people with the global incidence of around 7 cases per 100,000 people per year. The study also states that prevalence rates varies between ethnic and geographical latitudes, ranging from 50 to
Diabetic Foot Ulcers Treatment Market to Surpass US$ 9.49 Billion Threshold by 2 …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the

All 5 Releases


More Releases for Cannabis

Cannabis Market 2027 Top Players- Aphria, Inc.; Aurora Cannabis; Cannabis Scienc …
According to ournew market research study of “Cannabis Market to 2027 – Global Analysis and Forecast by Product Type, Compound and Application,” the market is expected to reach US$ 147,457.4 million by 2027 from US$ 14,383.8 million in 2019; it is estimated to grow at a CAGR of 29.1% from 2020 to 2027. The report highlights trends prevailing in the global cannabis market along with drivers and hindrances
Cannabis Market: Study Navigating the Future Growth Outlook | Aphria, Aurora Can …
An off-the-shelf report on Cannabis Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical
Cannabis Infused Products Market Worth Observing Growth|Canopy Growth, Aurora Ca …
Cannabis Infused Products Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to witness the growth at an annual pace of 22.0% in the forecast period. The growing awareness about the well-being and mental health benefits is driving the market scope of cannabis infused products. Cannabis infused products market is growing with the successive application of marijuana or
Cannabis Testing Market
Cannabis is a flowering plant predominantly found is Africa, Asia, and the Americas. Cannabis is non-conventionally used as a hemp fiber, hemp oils, used for medicinal resolutions, and as a frivolous drug. Industrial hemp crops are produced from the cannabis plants, which produce a plenty of fiber. To gratify the UN Narcotics Convention, some of the cannabis strains are raised to produce nominal levels of tetrahydrocannabinol, the main psychoactive component.
Cannabis Testing Market
Cannabis is a flowering plant predominantly found is Africa, Asia, and the Americas. Cannabis is non-conventionally used as a hemp fiber, hemp oils, used for medicinal resolutions, and as a frivolous drug. Industrial hemp crops are produced from the cannabis plants, which produce a plenty of fiber. To gratify the UN Narcotics Convention, some of the cannabis strains are raised to produce nominal levels of tetrahydrocannabinol, the main psychoactive component.
Cannabis Testing Market
Cannabis is a flowering plant predominantly found is Africa, Asia, and the Americas. Cannabis is non-conventionally used as a hemp fiber, hemp oils, used for medicinal resolutions, and as a frivolous drug. Industrial hemp crops are produced from the cannabis plants, which produce a plenty of fiber. To gratify the UN Narcotics Convention, some of the cannabis strains are raised to produce nominal levels of tetrahydrocannabinol, the main psychoactive component.